Literature DB >> 15132775

DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effect.

Takuya Iwamoto1, Yusuke Hiraku, Shinji Oikawa, Hideki Mizutani, Michio Kojima, Shosuke Kawanishi.   

Abstract

Busulfan (1,4-butanediol dimethanesulfonate) has been used widely for the treatment of patients with chronic myelogenous leukemia. Busulfan is bifunctional and thus may effectively induce DNA damage, which may play an important role in the cytotoxicity. In this study, we compared the cytotoxicity of bifunctional busulfan with that of monofunctional ethyl methanesulfonate (EMS) in human promyelocytic leukemia HL-60 cells. Busulfan showed a significant inhibitory effect on cell growth, whereas the cells grew in the presence of EMS. To clarify the mechanism of cytotoxicity of busulfan, we investigated DNA damage induced by busulfan using 32P-5'-end-labeled DNA fragments obtained from the human p16 tumor suppressor gene. Busulfan induced DNA damage dose-dependently, whereas EMS caused little DNA damage. DNA-sequencing experiments using piperidine and 3-methyladenine DNA glycosylase indicated that busulfan caused double-base lesions mainly at 5'-GA-3' and, to a lesser extent, at 5'-GG-3' sequences. Time of flight mass spectrometry confirmed that busulfan forms an intrastrand cross-link at the 5'-GA-3' sequence, in addition to mono-alkylation. The mechanism and the role of cross-linking at the 5'-GA-3' sequence are discussed in relation to the cytotoxicity induced by busulfan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15132775     DOI: 10.1111/j.1349-7006.2004.tb03231.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  39 in total

1.  Backbone Flexibility Influences Nucleotide Incorporation by Human Translesion DNA Polymerase η opposite Intrastrand Cross-Linked DNA.

Authors:  Derek K O'Flaherty; F Peter Guengerich; Martin Egli; Christopher J Wilds
Journal:  Biochemistry       Date:  2015-12-16       Impact factor: 3.162

2.  Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction.

Authors:  Arthur J L Cooper; Islam R Younis; Zoya V Niatsetskaya; Boris F Krasnikov; John T Pinto; William P Petros; Patrick S Callery
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

3.  The Myeloablative Drug Busulfan Converts Cysteine to Dehydroalanine and Lanthionine in Redoxins.

Authors:  Michele Scian; Miklos Guttman; Samantha D Bouldin; Caryn E Outten; William M Atkins
Journal:  Biochemistry       Date:  2016-08-11       Impact factor: 3.162

4.  Low-dose chemotherapeutic drugs induce reactive oxygen species and initiate apoptosis-mediated genomic instability.

Authors:  Renganathan Arun; Sridaran Dhivya; Suresh K Abraham; Kumpati Premkumar
Journal:  Toxicol Res (Camb)       Date:  2016-01-07       Impact factor: 3.524

5.  Computational approaches to find the active binding sites of biological targets against busulfan.

Authors:  T Karthick; Poonam Tandon
Journal:  J Mol Model       Date:  2016-05-30       Impact factor: 1.810

Review 6.  Reversible and irreversible protein glutathionylation: biological and clinical aspects.

Authors:  Arthur Jl Cooper; John T Pinto; Patrick S Callery
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-05-11       Impact factor: 4.481

7.  O6-2'-Deoxyguanosine-butylene-O6-2'-deoxyguanosine DNA Interstrand Cross-Links Are Replication-Blocking and Mutagenic DNA Lesions.

Authors:  Wenyan Xu; Daniel Kool; Derek K O'Flaherty; Ashley M Keating; Lauralicia Sacre; Martin Egli; Anne Noronha; Christopher J Wilds; Linlin Zhao
Journal:  Chem Res Toxicol       Date:  2016-11-04       Impact factor: 3.739

8.  Seminiferous epithelium damage after short period of busulphan treatment in adult rats and vitamin B12 efficacy in the recovery of spermatogonial germ cells.

Authors:  Sandi Regina Vasiliausha; Flávia Luciana Beltrame; Fabiane de Santi; Paulo Sérgio Cerri; Breno Henrique Caneguim; Estela Sasso-Cerri
Journal:  Int J Exp Pathol       Date:  2016-08-31       Impact factor: 1.925

9.  Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies.

Authors:  M Scalabrin; S M Dixit; M M Makshood; C E Krzemien; Daniele Fabris
Journal:  Methods       Date:  2018-05-10       Impact factor: 3.608

10.  Altered gene expression in busulfan-resistant human myeloid leukemia.

Authors:  Benigno C Valdez; David Murray; Latha Ramdas; Marcos de Lima; Roy Jones; Steven Kornblau; Daniel Betancourt; Yang Li; Richard E Champlin; Borje S Andersson
Journal:  Leuk Res       Date:  2008-03-12       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.